TET2 and lymphoid neoplasm: A large cohort of 28 patients reported many mutations, which are implicated in other myeloid malignancies, e.g., TET2, MLL4, NF1, ALK, and ASXL1; many of these genes are driver mutations in different myeloid and lymphoid neoplasms [59].